Bausch + Lomb Names Thomas J. Appio Interim CEO, Expects to Raise 2026 Guidance
Bausch + Lomb and Bausch Health announced Thomas J. Appio’s appointment as interim Bausch + Lomb CEO and said they expect to raise full-year 2026 guidance.
Bausch + Lomb and Bausch Health announced Thomas J. Appio’s appointment as interim Bausch + Lomb CEO and said they expect to raise full-year 2026 guidance.